🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of the study is to learn about the safety of MK-2060 and if people...
Status
Completed
Location
Advanced Pharma CR, LLC ( Site 0002)
Start Date
2024-10-15
Trial ID
NCT06582602
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Orlando Clinical Research Center ( Site 0002)
Start Date
2019-04-29
Trial ID
NCT03873038
The purpose of this study is to evaluate the efficacy and safety of two dif...
Status
Completed
Location
Nephrology Consultants ( Site 0681)
Start Date
2021-09-17
Trial ID
NCT05027074
The purpose of this study is to assess the safety, tolerability, pharmacoki...
Status
Completed
Location
Kasugai Municipal Hospital ( Site 1203)
Start Date
2023-06-14
Trial ID
NCT05769595
This was intended as a three-part study of MK-2060 in participants with chr...
Status
Completed
Location
Velocity Clinical Research, New Smyrna Beach ( Site 0003)
Start Date
2023-02-08
Trial ID
NCT05656040
MK-2060 is being developed for prevention of thrombotic complications in en...
Status
Completed
Location
Genesis Clinical Research, LLC ( Site 0003)
Start Date
2022-05-30
Trial ID
NCT05335005
Treatments Being Tested
The goal of the study is to learn about the safety of MK-2060 and if people...
Status
Completed
Location
Zhongshan Hospital,Fudan University-Dep. of Clinical Pharmacology (Site 001)
Start Date
2023-03-01
Trial ID
NCT06843993